The effect of PS-341 on pulmonary vascular remodeling in high blood flow-induced pulmonary hypertension

12Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

The aim of the present study was to investigate the effects of PS-341 on vascular remodeling in an experimental rat model of high blood flow-induced pulmonary arterial hypertension (PAH), as well as to elucidate its mechanisms of action. We established the PAH model by a surgical method that implanted a left-to-right shunt. Three days post-surgery, the animals were randomly assigned to 3 groups (n=15 in each group): sham-operated (control), shunt (model) and PS-341 (treated) groups. Eight weeks post-surgery, hemodynamic parameters were significantly improved in the PS-341 group compared with the shunt group (P<0.05). Immunohistochemical analysis indicated that the expression levels of ubiquitin and nuclear factor-κB (NF-κB) p65 were significantly higher in the shunt group compared with the sham-operated group (P<0.05). Semi-quantitative western blot analysis further confirmed that the levels of ubiquitin and NF-κB p65 were decreased, while those of IκB-α (an inhibitor of NF-κB) were significantly increased in the PS-341 group compared with the shunt group (P<0.05). In conclusion, PS-341 attenuates high blood flow-induced pulmonary artery remodeling in rats via inhibition of the NF-κB pathway.

References Powered by Scopus

Mechanism of activation of the TGF-β receptor

2201Citations
N/AReaders
Get full text

Mechanisms of disease: Pulmonary arterial hypertension

1118Citations
N/AReaders
Get full text

Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis

409Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats

48Citations
N/AReaders
Get full text

Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response

45Citations
N/AReaders
Get full text

Bortezomib alleviates experimental pulmonary hypertension by regulating intracellular calcium homeostasis in PASMCs

26Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhang, X., Wang, Z. S., Luan, Y., Lin, M., Zhu, X. B., Ma, Y., … Wang, Y. B. (2014). The effect of PS-341 on pulmonary vascular remodeling in high blood flow-induced pulmonary hypertension. International Journal of Molecular Medicine, 33(1), 105–110. https://doi.org/10.3892/ijmm.2013.1562

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

38%

Researcher 3

38%

Professor / Associate Prof. 1

13%

Lecturer / Post doc 1

13%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

50%

Agricultural and Biological Sciences 2

25%

Biochemistry, Genetics and Molecular Bi... 1

13%

Nursing and Health Professions 1

13%

Save time finding and organizing research with Mendeley

Sign up for free